{"protocolSection":{"identificationModule":{"nctId":"NCT05089630","orgStudyIdInfo":{"id":"209976"},"organization":{"fullName":"GlaxoSmithKline","class":"INDUSTRY"},"briefTitle":"A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults","officialTitle":"A Phase 1/2, First-Time-in Human (FTiH), Randomized, Observer-blind, Placebo-controlled, Dose Escalation Study to Assess Safety, Reactogenicity and Immunogenicity of a Candidate Cytomegalovirus (CMV) Vaccine Comprising Recombinant Protein and Adjuvant When Administered Intramuscularly in Healthy Adults"},"statusModule":{"statusVerifiedDate":"2026-07","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-10-14","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-04-02","type":"ACTUAL"},"completionDateStruct":{"date":"2025-04-02","type":"ACTUAL"},"studyFirstSubmitDate":"2021-10-11","studyFirstSubmitQcDate":"2021-10-11","studyFirstPostDateStruct":{"date":"2021-10-22","type":"ACTUAL"},"resultsFirstSubmitDate":"2026-03-31","resultsFirstSubmitQcDate":"2026-07-16","resultsFirstPostDateStruct":{"date":"2026-07-17","type":"ACTUAL"},"lastUpdateSubmitDate":"2026-07-16","lastUpdatePostDateStruct":{"date":"2026-07-17","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"GlaxoSmithKline","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false,"isUsExport":true},"descriptionModule":{"briefSummary":"The purpose of this study is to assess the safety, reactogenicity and immune response of the candidate CMV recombinant protein subunit (CMVsu) vaccine consisting of a combination of glycoproteins B (gB) and pentamer antigens adjuvanted, regardless of baseline CMV sero-status. This FTiH study is conducted in healthy adults 18 to 50 years of age, in which the 4 dose levels of the vaccine are administered in a step-wise dose escalation manner, based upon safety adjudication."},"conditionsModule":{"conditions":["Cytomegalovirus Infections"],"keywords":["Cytomegalovirus","First-Time-in Human","Safety","Reactogenicity","Immunogenicity","Healthy adults"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1","PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":333,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Pentamer (low dose)/glycoprotein B (gB) (low dose)/Adjuvant group","type":"EXPERIMENTAL","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly.","interventionNames":["Biological: Pentamer (low)/gB(low)/Adjuvant vaccine"]},{"label":"Pentamer (medium dose)/gB (low dose)/Adjuvant group","type":"EXPERIMENTAL","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly.","interventionNames":["Biological: Pentamer (med)/gB(low)/Adjuvant vaccine"]},{"label":"Pentamer (medium dose)/gB (medium dose)/Adjuvant group","type":"EXPERIMENTAL","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly.","interventionNames":["Biological: Pentamer (med)/gB(med)/Adjuvant vaccine"]},{"label":"Pentamer (high dose)/gB (medium dose)/Adjuvant group","type":"EXPERIMENTAL","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly.","interventionNames":["Biological: Pentamer (high)/gB(med)/Adjuvant vaccine"]},{"label":"Placebo Group","type":"PLACEBO_COMPARATOR","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly.","interventionNames":["Combination Product: Placebo (saline solution)"]}],"interventions":[{"type":"BIOLOGICAL","name":"Pentamer (low)/gB(low)/Adjuvant vaccine","description":"Three doses of the candidate CMVsu vaccine consisting of a combination of low dose pentamer and low dose gB antigens, adjuvanted are administered intramuscularly in the deltoid region of the non-dominant arm in a 0, 2, 6-month schedule.","armGroupLabels":["Pentamer (low dose)/glycoprotein B (gB) (low dose)/Adjuvant group"]},{"type":"BIOLOGICAL","name":"Pentamer (med)/gB(low)/Adjuvant vaccine","description":"Three doses of the candidate CMVsu vaccine consisting of a combination of medium dose pentamer and low dose gB antigens, adjuvanted are administered intramuscularly in the deltoid region of the non-dominant arm in a 0, 2, 6-month schedule.","armGroupLabels":["Pentamer (medium dose)/gB (low dose)/Adjuvant group"]},{"type":"BIOLOGICAL","name":"Pentamer (med)/gB(med)/Adjuvant vaccine","description":"Three doses of the candidate CMVsu vaccine consisting of a combination of medium dose pentamer and medium dose gB antigens, adjuvanted are administered intramuscularly in the deltoid region of the non-dominant arm in a 0, 2, 6-month schedule.","armGroupLabels":["Pentamer (medium dose)/gB (medium dose)/Adjuvant group"]},{"type":"BIOLOGICAL","name":"Pentamer (high)/gB(med)/Adjuvant vaccine","description":"Three doses of the candidate CMVsu vaccine consisting of a combination of high dose pentamer and medium dose gB antigens, adjuvanted are administered intramuscularly in the deltoid region of the non-dominant arm in a 0, 2, 6-month schedule.","armGroupLabels":["Pentamer (high dose)/gB (medium dose)/Adjuvant group"]},{"type":"COMBINATION_PRODUCT","name":"Placebo (saline solution)","description":"Three doses of placebo (saline) are administered intramuscularly in the deltoid region of the non-dominant arm in a 0, 2, 6-month schedule.","armGroupLabels":["Placebo Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Participants With Solicited Administration Site Adverse Events Post Each Dose Administration","description":"The assessed solicited administration site adverse events were erythema (injection site redness), pain and swelling.","timeFrame":"Within 7 days post each dose (doses administered on Day 1, Day 61 and Day 181)"},{"measure":"Number of Participants With Solicited Systemic Adverse Events Post Each Dose Administration","description":"The assessed solicited administration site adverse events were arthralgia, fatigue, headache, fever and myalgia. Fever was defined as body temperature ≥38.0°Celsius/100.4°Fahrenheit.","timeFrame":"Within 7 days post each dose (doses administered on Day 1, Day 61 and Day 181)"},{"measure":"Number of Participants With Unsolicited Adverse Events (AEs) Within 7 Days Post Each Dose Administration","description":"An unsolicited AE is defined as an AE that was not included in a list of solicited events using a Participant Diary. Unsolicited AEs include both serious and non-serious AEs.","timeFrame":"Within 7 days post each dose (doses administered on Day 1, Day 61 and Day 181)"},{"measure":"Number of Participants With Unsolicited Serious Adverse Events (SAEs) Within 7 Days Post Each Dose Administration","description":"An SAE is defined as any untoward medical occurrence that, at any dose, resulted in death, was life-threatening, required hospitalization or prolongation of existing hospitalization, resulted in disability/incapacity, caused a congenital anomaly/birth defect, or was any other situation identified according to medical or scientific judgment. An unsolicited SAE is defined as an SAE that was not included in a list of solicited events using a Participant Diary.","timeFrame":"Within 7 days post each dose (doses administered on Day 1, Day 61 and Day 181)"},{"measure":"Number of Participants With Unsolicited AEs up to 30 Days Post Each Dose Administration","description":"An unsolicited AE is defined as an AE that was not included in a list of solicited events using a Participant Diary. The solicited AEs that had an onset after 7 days post each dose administration are considered unsolicited AEs. Unsolicited AEs include both serious and non-serious AEs.","timeFrame":"Within 30 days post each dose (doses administered on Day 1, Day 61 and Day 181)"},{"measure":"Number of Participants With Unsolicited SAEs up to 30 Days Post Each Dose Administration","timeFrame":"Within 30 days post each dose (doses administered on Day 1, Day 61 and Day 181)"},{"measure":"Number of Participants With Medically Attended Events (MAEs) up to 30 Days Post Each Dose Administration","description":"MAE is defined as an AE for which the participant received medical attention defined as hospitalization, an emergency room visit or a visit to or from medical personnel (i.e., nurse practitioner or physician assistant or medical doctor) for any reason.","timeFrame":"Within 30 days post each dose (doses administered on Day 1, Day 61 and Day 181)"},{"measure":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 1","description":"The hematological and biochemical parameters included alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, white blood cells (WBC). Categories reported when comparing normal range and Day 1 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","timeFrame":"On Day 1"},{"measure":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 8","description":"The hematological and biochemical parameters included ALT, AST, creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, WBC. Categories reported when comparing normal range and Day 8 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","timeFrame":"On Day 8"},{"measure":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 61","description":"The hematological and biochemical parameters included ALT, AST, creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, WBC. Categories reported when comparing normal range and Day 61 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","timeFrame":"On Day 61"},{"measure":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 68","description":"The hematological and biochemical parameters included ALT, AST, creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, WBC. Categories reported when comparing normal range and Day 68 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","timeFrame":"On Day 68"},{"measure":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 181","description":"The hematological and biochemical parameters included ALT, AST, creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, WBC. Categories reported when comparing normal range and Day 181 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","timeFrame":"On Day 181"},{"measure":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 188","description":"The hematological and biochemical parameters included ALT, AST, creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, WBC. Categories reported when comparing normal range and Day 188 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","timeFrame":"On Day 188"}],"secondaryOutcomes":[{"measure":"Number of Participants With Unsolicited Events, SAEs, MAEs and Potential Immune Mediated Diseases (pIMDs) From Day 1 to Day 546 (End of Study)","description":"Unsolicited AE=AE that was not included in a list of solicited events using a Participant Diary; the solicited AEs that had an onset after 7 days post each dose administration are considered unsolicited AEs; both serious and non-serious AEs are included. SAE=any untoward medical occurrence that, at any dose, resulted in death, was life-threatening, required hospitalization or prolongation of existing hospitalization, resulted in disability/incapacity, caused a congenital anomaly/birth defect, or was any other situation identified according to medical or scientific judgment. MAE=AE for which the participant received medical attention defined as hospitalization, an emergency room visit or a visit to or from medical personnel (i.e., nurse practitioner or physician assistant or medical doctor) for any reason. pIMDs=a subset of adverse events that include autoimmune diseases and other inflammatory and/or neurological disorders of interest which may or may not have an autoimmune etiology.","timeFrame":"Day 1 to Day 546"},{"measure":"Geometric Mean Titers (GMT) of Neutralizing Antibodies (nAbs) Against Epithelial Cell Infection (CMV Status: Sero-positive)","description":"Neutralizing antibodies (nAbs) against epithelial cell infection were measured with neutralizing assay and the results were expressed as GMT.","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546"},{"measure":"GMT of nAbs Against Epithelial Cell Infection (CMV Status: Sero-negative)","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546"},{"measure":"Geometric Mean Concentration (GMC) of Anti-pentamer Immunoglobulin G (IgG) (CMV Serostaus: Sero-positive)","description":"The vaccine-induced humoral immunity was quantified by measuring the concentration of the anti-pentamer by enzyme-linked immunosorbent assay (ELISA).","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546"},{"measure":"GMC of Anti-pentamer IgG (CMV Serostatus: Sero-negative)","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546"},{"measure":"GMC of Anti-glycoprotein B (gB) IgG (CMV Serostaus: Sero-positive)","description":"The vaccine-induced humoral immunity was quantified by measuring the concentration of the anti-gB IgG binding antibodies by ELISA.","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546"},{"measure":"GMC of Anti-gB IgG (CMV Serostatus: Sero-negative)","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Participants who, in the opinion of the investigator, can and will comply with the requirements of the protocol.\n* Written informed consent obtained from the participant prior to performance of any study specific procedure.\n* A healthy adult (woman or man), 18 to 50 years of age at the time of the first study intervention administration.\n* Healthy participants as established by medical history and clinical examination before entering the study.\n* Participants who are women of non-childbearing potential may be enrolled in the study.\n* Participants who are women of child-bearing potential may be enrolled in the study, if the participant:\n\n  * has practiced adequate contraception for 30 days prior to study intervention administration, and\n  * has a negative pregnancy test on the day of study intervention administration and\n  * has agreed to continue adequate contraception during the entire treatment period and for 3 months after completion of the study intervention administration series.\n* Participants who agree to take appropriate infection control measures to prevent becoming infected with SARS-CoV2 during the study.\n* Participants who initially fail screening due to COVID-19 infection may be re-screened and included in the study, within the screening window period.\n* Participants with signs/symptoms suggestive of active COVID-19 (i.e., fever, cough, etc.) should be isolated for the time period recommended by CDC since the signs/symptoms started, and symptoms have resolved.\n* Participants with known COVID-19 positive contacts should be quarantined for the time period since exposure recommended by CDC since the exposure and the participant remains symptom free or COVID test negative.\n* Participants who are diagnosed with COVID-19 may receive their subsequent CMVsu vaccination dose provided they have no fever, and their condition is considered stable by the investigator (e.g., there may be mild lingering cough, but no shortness of breath or difficulty breathing) within the original schedule.\n* Participants who initially fail screening due to other active infections may be re screened within the screening window period and included in the study, if they no longer have signs or symptoms of active infection in the judgment of the site investigator.\n* If a participant has equivocal results on CMV serodiagnostic screening test, they are permitted to be re-screened if within the 60-day screening window. Flexibility in safety blood evaluations will be permitted within the Schedule of activities time intervals.\n\nExclusion Criteria:\n\nMedical conditions\n\n* Known documented medical history of or viral hepatitis B or C infection.\n* History of any reaction or hypersensitivity likely to be exacerbated by any component of the study intervention(s).\n* Any confirmed or suspected immunosuppressive or immunodeficient condition.\n* Family history of congenital or hereditary immunodeficiency.\n* History of or current autoimmune disease.\n* Lymphoproliferative disorder or malignancy within previous 5 years (excluding effectively treated non-melanotic skin cancer).\n* Hypersensitivity to latex.\n* Major congenital defects\n* Acute or chronic clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality.\n* Recurrent history or uncontrolled neurological disorders.\n* Any hematological or biochemical abnormality.\n* Any acute or chronic, clinically significant disease or pulmonary, cardiovascular, hepatic, or renal functional abnormalities.\n* Any medical condition that in the judgment of the investigator would make intramuscular injection unsafe.\n* Participants with symptoms suggestive of active COVID-19 infection are excluded.\n* Participants with known COVID-19 positive contacts within the past 14 days should be excluded for at least 14 days since the exposure and the participant remains symptom free.\n* Any other clinical condition that, might pose additional risk to the participant due to participation in the study.\n\nPrior/Concomitant therapy\n\n* Any history of or planned receipt of a CMV vaccine other than the study intervention at any time point.\n* Use of other investigational/non-registered product during the period beginning 30 days before the first dose, or their planned use during the study period.\n* Planned administration of any vaccine not foreseen by the study protocol 30 days before and 30 days after each study vaccination administration any licensed influenza vaccine administered \\> 15 days before/ after vaccination.\n* In case of extraordinary emergency mass vaccination for an unforeseen public health threat the time period can be reduced if necessary, for that mass vaccination vaccine, which may be under emergency use authorization.\n\n  * COVID-19 vaccines should be given at least 30 days before or after administration of a GSK study vaccine. This interval can be reduced to \\> 14 days, if emergency vaccination is recommended by public health authorities.\n  * Candidate COVID-19 vaccines are not allowed.\n* Chronic administration of immunosuppressants or other immune-modifying drugs within 3 months prior to the vaccine dose. Inhaled and topical steroids are allowed.\n* Administration of long-acting immune-modifying drugs at any time during the study period.\n* Administration of immunoglobulins and/or any blood products during the period starting 3 months before the administration of the first dose of study intervention(s) or planned administration during the study period.\n\nPrior/Concurrent clinical study experience\n\n• Concurrently participating in another clinical study, at any time during the study period, in which the participant has been or will be exposed to an investigational or a non-investigational intervention\n\nOther exclusions\n\n* Pregnant or lactating women. If a woman becomes pregnant/lactating during the study, she will be excluded from subsequent vaccine doses but will be followed for safety.\n* Women planning to become pregnant or planning to discontinue contraceptive precautions before 3 months after last study vaccination.\n* Participants with known high exposure risk for CMV transmission, to enable distinction of true vaccine effect from natural infection during the study.\n* Planned move to a location that will prohibit participating in the trial until study end.\n* Participants with current chronic alcohol consumption and/or drug abuse as defined by Diagnostic and Statistical Manual of Mental Disorders 5th edition.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"50 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"GSK Investigational Site","city":"Anaheim","state":"California","zip":"92806","country":"United States","geoPoint":{"lat":33.83529,"lon":-117.9145}},{"facility":"GSK Investigational Site","city":"Long Beach","state":"California","zip":"90806","country":"United States","geoPoint":{"lat":33.76696,"lon":-118.18923}},{"facility":"GSK Investigational Site","city":"Los Angeles","state":"California","zip":"90017","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"GSK Investigational Site","city":"Hallandale","state":"Florida","zip":"33009","country":"United States","geoPoint":{"lat":25.9812,"lon":-80.14838}},{"facility":"GSK Investigational Site","city":"Miami","state":"Florida","zip":"33143","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"GSK Investigational Site","city":"Lexington","state":"Kentucky","zip":"40536-0084","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"GSK Investigational Site","city":"Dearborn","state":"Michigan","zip":"48127","country":"United States","geoPoint":{"lat":42.32226,"lon":-83.17631}},{"facility":"GSK Investigational Site","city":"Springfield","state":"Missouri","zip":"65802","country":"United States","geoPoint":{"lat":37.21533,"lon":-93.29824}},{"facility":"GSK Investigational Site","city":"Lincoln","state":"Nebraska","zip":"68510","country":"United States","geoPoint":{"lat":40.8,"lon":-96.66696}},{"facility":"GSK Investigational Site","city":"Omaha","state":"Nebraska","zip":"68134","country":"United States","geoPoint":{"lat":41.25626,"lon":-95.94043}},{"facility":"GSK Investigational Site","city":"Las Vegas","state":"Nevada","zip":"89109","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"GSK Investigational Site","city":"Newark","state":"New Jersey","zip":"07103","country":"United States","geoPoint":{"lat":40.73566,"lon":-74.17237}},{"facility":"GSK Investigational Site","city":"Secaucus","state":"New Jersey","zip":"07094","country":"United States","geoPoint":{"lat":40.78955,"lon":-74.05653}},{"facility":"GSK Investigational Site","city":"New York","state":"New York","zip":"10065","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"GSK Investigational Site","city":"Austin","state":"Texas","zip":"78744-1645","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"GSK Investigational Site","city":"Cedar Park","state":"Texas","zip":"78613","country":"United States","geoPoint":{"lat":30.5052,"lon":-97.82029}},{"facility":"GSK Investigational Site","city":"Galveston","state":"Texas","zip":"77573","country":"United States","geoPoint":{"lat":29.30135,"lon":-94.7977}},{"facility":"GSK Investigational Site","city":"Puyallup","state":"Washington","zip":"98371","country":"United States","geoPoint":{"lat":47.18538,"lon":-122.2929}}]},"referencesModule":{"references":[{"pmid":"38503664","type":"DERIVED","citation":"Sanchez-Martinez ZV, Alpuche-Lazcano SP, Stuible M, Durocher Y. CHO cells for virus-like particle and subunit vaccine manufacturing. Vaccine. 2024 Apr 11;42(10):2530-2542. doi: 10.1016/j.vaccine.2024.03.034. Epub 2024 Mar 19."}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"Study Sponsor will assess requests from qualified researchers for anonymized individual patient-level data and related study documents. Data sharing is subject to certain criteria, conditions, and exceptions. For further information, refer to https://d3l8i7lo48obsd.cloudfront.net/gsk-patient-level-data-sharing-july2025-1-Bgwa1UthxvluYbWYTThw.pdf","infoTypes":["STUDY_PROTOCOL","SAP","ICF","CSR"],"timeFrame":"Anonymized IPD will be made available within 6 months of publication of primary, key secondary and safety results for studies in product with approved indication(s) or asset(s) with development terminated across all indications.","accessCriteria":"Anonymized IPD is shared with researchers whose proposals are approved by an Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months, but an extension may be granted, when justified, for up to 6 months.","url":"https://d3l8i7lo48obsd.cloudfront.net/gsk-patient-level-data-sharing-july2025-1-Bgwa1UthxvluYbWYTThw.pdf"}},"resultsSection":{"participantFlowModule":{"recruitmentDetails":"Out of 333 enrolled participants, only 329 participants started the study and were included in the Exposed Set.","groups":[{"id":"FG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"FG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"FG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"FG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"FG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"69"},{"groupId":"FG001","numSubjects":"61"},{"groupId":"FG002","numSubjects":"60"},{"groupId":"FG003","numSubjects":"60"},{"groupId":"FG004","numSubjects":"79"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"44"},{"groupId":"FG001","numSubjects":"38"},{"groupId":"FG002","numSubjects":"37"},{"groupId":"FG003","numSubjects":"43"},{"groupId":"FG004","numSubjects":"44"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"25"},{"groupId":"FG001","numSubjects":"23"},{"groupId":"FG002","numSubjects":"23"},{"groupId":"FG003","numSubjects":"17"},{"groupId":"FG004","numSubjects":"35"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"14"},{"groupId":"FG001","numSubjects":"9"},{"groupId":"FG002","numSubjects":"5"},{"groupId":"FG003","numSubjects":"5"},{"groupId":"FG004","numSubjects":"17"}]},{"type":"Withdrawal by Subject, Not Due to an Adverse Avent","reasons":[{"groupId":"FG000","numSubjects":"7"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"5"},{"groupId":"FG003","numSubjects":"4"},{"groupId":"FG004","numSubjects":"6"}]},{"type":"Migrated/Moved from the Study Area","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"2"}]},{"type":"Temperature Excursion","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"}]},{"type":"Study Dose Not Administered","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"1"}]},{"type":"Death Due to Road Traffic Accident","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"}]},{"type":"Other","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"9"},{"groupId":"FG002","numSubjects":"11"},{"groupId":"FG003","numSubjects":"6"},{"groupId":"FG004","numSubjects":"9"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"BG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"BG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"BG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"BG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"BG005","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"69"},{"groupId":"BG001","value":"61"},{"groupId":"BG002","value":"60"},{"groupId":"BG003","value":"60"},{"groupId":"BG004","value":"79"},{"groupId":"BG005","value":"329"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"YEARS","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"34.9","spread":"9.6"},{"groupId":"BG001","value":"33.0","spread":"8.8"},{"groupId":"BG002","value":"35.0","spread":"8.9"},{"groupId":"BG003","value":"32.2","spread":"9.5"},{"groupId":"BG004","value":"36.9","spread":"8.5"},{"groupId":"BG005","value":"34.6","spread":"9.2"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"30"},{"groupId":"BG002","value":"34"},{"groupId":"BG003","value":"35"},{"groupId":"BG004","value":"38"},{"groupId":"BG005","value":"172"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"26"},{"groupId":"BG003","value":"25"},{"groupId":"BG004","value":"41"},{"groupId":"BG005","value":"157"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Black or African American","categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"13"},{"groupId":"BG003","value":"12"},{"groupId":"BG004","value":"13"},{"groupId":"BG005","value":"66"}]}]},{"title":"Asian","categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"6"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"18"}]}]},{"title":"Native Hawaiian or Other Pacific Islander","categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"1"}]}]},{"title":"White","categories":[{"measurements":[{"groupId":"BG000","value":"49"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"38"},{"groupId":"BG003","value":"37"},{"groupId":"BG004","value":"63"},{"groupId":"BG005","value":"230"}]}]},{"title":"Missing","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"3"}]}]},{"title":"Other","categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"11"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Solicited Administration Site Adverse Events Post Each Dose Administration","description":"The assessed solicited administration site adverse events were erythema (injection site redness), pain and swelling.","populationDescription":"The analysis was performed on the Solicited Safety Set which included all participants who received at least 1 dose of the study intervention (Exposed Set) who have solicited safety data. Only the participants with solicited administration site adverse events data available at the specified time period were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days post each dose (doses administered on Day 1, Day 61 and Day 181)","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"classes":[{"title":"Erythema, Within 7 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"}]}]},{"title":"Erythema, Within 7 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"62"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"}]}]},{"title":"Erythema, Within 7 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"52"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]},{"title":"Pain, Within 7 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"41"},{"groupId":"OG004","value":"2"}]}]},{"title":"Pain, Within 7 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"62"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"38"},{"groupId":"OG002","value":"39"},{"groupId":"OG003","value":"39"},{"groupId":"OG004","value":"2"}]}]},{"title":"Pain, Within 7 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"52"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"29"},{"groupId":"OG004","value":"1"}]}]},{"title":"Swelling, Within 7 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"}]}]},{"title":"Swelling, Within 7 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"62"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"0"}]}]},{"title":"Swelling, Within 7 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"52"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Solicited Systemic Adverse Events Post Each Dose Administration","description":"The assessed solicited administration site adverse events were arthralgia, fatigue, headache, fever and myalgia. Fever was defined as body temperature ≥38.0°Celsius/100.4°Fahrenheit.","populationDescription":"The analysis was performed on the Solicited Safety Set. Only the participants with solicited systemic adverse events data available at the specified timepoints were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days post each dose (doses administered on Day 1, Day 61 and Day 181)","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"classes":[{"title":"Arthralgia, Within 7 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"1"}]}]},{"title":"Arthralgia, Within 7 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"62"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"0"}]}]},{"title":"Arthralgia, Within 7 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"52"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"3"}]}]},{"title":"Fatigue, Within 7 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"24"},{"groupId":"OG004","value":"14"}]}]},{"title":"Fatigue, Within 7 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"62"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"},{"groupId":"OG004","value":"4"}]}]},{"title":"Fatigue, Within 7 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"52"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"19"},{"groupId":"OG004","value":"8"}]}]},{"title":"Fever, Within 7 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"}]}]},{"title":"Fever, Within 7 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"62"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"}]}]},{"title":"Fever, Within 7 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"52"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"}]}]},{"title":"Headache, Within 7 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"20"},{"groupId":"OG004","value":"8"}]}]},{"title":"Headache, Within 7 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"62"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"22"},{"groupId":"OG004","value":"5"}]}]},{"title":"Headache, Within 7 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"52"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"15"},{"groupId":"OG004","value":"6"}]}]},{"title":"Myalgia, Within 7 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"29"},{"groupId":"OG004","value":"5"}]}]},{"title":"Myalgia, Within 7 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"62"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"33"},{"groupId":"OG004","value":"3"}]}]},{"title":"Myalgia, Within 7 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"52"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"24"},{"groupId":"OG004","value":"1"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Unsolicited Adverse Events (AEs) Within 7 Days Post Each Dose Administration","description":"An unsolicited AE is defined as an AE that was not included in a list of solicited events using a Participant Diary. Unsolicited AEs include both serious and non-serious AEs.","populationDescription":"The analysis was performed on the Unsolicited Safety Set, which included all participants who received at least 1 dose of the study intervention (Exposed Set) that report unsolicited AEs/report not having unsolicited AEs. Only the participants with unsolicited AEs data available at the specified time period were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days post each dose (doses administered on Day 1, Day 61 and Day 181)","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"classes":[{"title":"Within 7 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"4"}]}]},{"title":"Within 7 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"3"}]}]},{"title":"Within 7 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"1"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Unsolicited Serious Adverse Events (SAEs) Within 7 Days Post Each Dose Administration","description":"An SAE is defined as any untoward medical occurrence that, at any dose, resulted in death, was life-threatening, required hospitalization or prolongation of existing hospitalization, resulted in disability/incapacity, caused a congenital anomaly/birth defect, or was any other situation identified according to medical or scientific judgment. An unsolicited SAE is defined as an SAE that was not included in a list of solicited events using a Participant Diary.","populationDescription":"The analysis was performed on the Unsolicited Safety Set. Only the participants with unsolicited SAEs data available at the specified time period were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days post each dose (doses administered on Day 1, Day 61 and Day 181)","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"classes":[{"title":"Within 7 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Within 7 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Within 7 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Unsolicited AEs up to 30 Days Post Each Dose Administration","description":"An unsolicited AE is defined as an AE that was not included in a list of solicited events using a Participant Diary. The solicited AEs that had an onset after 7 days post each dose administration are considered unsolicited AEs. Unsolicited AEs include both serious and non-serious AEs.","populationDescription":"The analysis was performed on the Unsolicited Safety Set. Only the participants with unsolicited AEs data available at the specified time period were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 30 days post each dose (doses administered on Day 1, Day 61 and Day 181)","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"classes":[{"title":"Within 30 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"13"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"9"}]}]},{"title":"Within 30 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"7"}]}]},{"title":"Within 30 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"5"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Unsolicited SAEs up to 30 Days Post Each Dose Administration","populationDescription":"The analysis was performed on the Unsolicited Safety Set. Only the participants with unsolicited SAEs data available at the specified time period were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 30 days post each dose (doses administered on Day 1, Day 61 and Day 181)","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"classes":[{"title":"Within 30 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Within 30 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Within 30 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Medically Attended Events (MAEs) up to 30 Days Post Each Dose Administration","description":"MAE is defined as an AE for which the participant received medical attention defined as hospitalization, an emergency room visit or a visit to or from medical personnel (i.e., nurse practitioner or physician assistant or medical doctor) for any reason.","populationDescription":"The analysis was performed on the Unsolicited Safety Set. Only the participants with MAEs data available at the specified time period were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 30 days post each dose (doses administered on Day 1, Day 61 and Day 181)","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"classes":[{"title":"Within 30 days from dosing at Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"3"}]}]},{"title":"Within 30 days from dosing at Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"3"}]}]},{"title":"Within 30 days from dosing at Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 1","description":"The hematological and biochemical parameters included alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, white blood cells (WBC). Categories reported when comparing normal range and Day 1 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","populationDescription":"The analysis was performed on the Exposed set, which included all participants who received at least 1 dose of the study intervention. Only the participants with data available for the specified laboratory parameters at Day 1 were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"On Day 1","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"classes":[{"title":"ALT, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"56"},{"groupId":"OG002","value":"57"},{"groupId":"OG003","value":"59"},{"groupId":"OG004","value":"76"}]}]},{"title":"ALT, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"}]}]},{"title":"ALT, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]},{"title":"AST, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"57"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"59"},{"groupId":"OG004","value":"76"}]}]},{"title":"AST, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"}]}]},{"title":"AST, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Creatinine, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Creatinine, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"56"},{"groupId":"OG002","value":"57"},{"groupId":"OG003","value":"59"},{"groupId":"OG004","value":"72"}]}]},{"title":"Creatinine, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"6"}]}]},{"title":"Creatinine, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Eosinophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"5"}]}]},{"title":"Eosinophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"54"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"71"}]}]},{"title":"Eosinophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"}]}]},{"title":"Eosinophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Hemoglobin, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"8"}]}]},{"title":"Hemoglobin, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"54"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"69"}]}]},{"title":"Hemoglobin, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]},{"title":"Hemoglobin, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"78"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"WBC, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"}]}]},{"title":"WBC, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"56"},{"groupId":"OG002","value":"58"},{"groupId":"OG003","value":"57"},{"groupId":"OG004","value":"74"}]}]},{"title":"WBC, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"}]}]},{"title":"WBC, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"57"},{"groupId":"OG004","value":"77"}]}]},{"title":"Lymphocytes, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"}]}]},{"title":"Neutrophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"54"},{"groupId":"OG002","value":"56"},{"groupId":"OG003","value":"57"},{"groupId":"OG004","value":"74"}]}]},{"title":"Neutrophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"1"}]}]},{"title":"Neutrophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"59"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"59"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"57"},{"groupId":"OG003","value":"58"},{"groupId":"OG004","value":"76"}]}]},{"title":"Platelets, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"59"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]},{"title":"Platelets, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"59"},{"groupId":"OG003","value":"59"},{"groupId":"OG004","value":"77"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 8","description":"The hematological and biochemical parameters included ALT, AST, creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, WBC. Categories reported when comparing normal range and Day 8 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","populationDescription":"The analysis was performed on the Exposed set. Only the participants with data available for the specified laboratory parameters at Day 8 were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"On Day 8","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"69"}]}],"classes":[{"title":"ALT, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"56"},{"groupId":"OG002","value":"51"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"64"}]}]},{"title":"ALT, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"4"}]}]},{"title":"ALT, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]},{"title":"AST, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"68"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"63"},{"groupId":"OG001","value":"57"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"64"}]}]},{"title":"AST, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"68"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"4"}]}]},{"title":"AST, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"68"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Creatinine, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Creatinine, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"54"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"64"}]}]},{"title":"Creatinine, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"5"}]}]},{"title":"Creatinine, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Eosinophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"2"}]}]},{"title":"Eosinophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"63"},{"groupId":"OG001","value":"56"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"63"}]}]},{"title":"Eosinophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"}]}]},{"title":"Eosinophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Hemoglobin, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"9"}]}]},{"title":"Hemoglobin, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"48"},{"groupId":"OG002","value":"47"},{"groupId":"OG003","value":"47"},{"groupId":"OG004","value":"56"}]}]},{"title":"Hemoglobin, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Hemoglobin, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"WBC, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"}]}]},{"title":"WBC, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"56"},{"groupId":"OG002","value":"52"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"62"}]}]},{"title":"WBC, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"}]}]},{"title":"WBC, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"55"},{"groupId":"OG004","value":"65"}]}]},{"title":"Lymphocytes, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"3"}]}]},{"title":"Neutrophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"55"},{"groupId":"OG002","value":"52"},{"groupId":"OG003","value":"54"},{"groupId":"OG004","value":"61"}]}]},{"title":"Neutrophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"}]}]},{"title":"Neutrophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"56"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"55"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"55"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"55"},{"groupId":"OG002","value":"52"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"64"}]}]},{"title":"Platelets, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"55"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"}]}]},{"title":"Platelets, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"55"},{"groupId":"OG004","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 61","description":"The hematological and biochemical parameters included ALT, AST, creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, WBC. Categories reported when comparing normal range and Day 61 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","populationDescription":"The analysis was performed on the Exposed set. Only the participants with data available for the specified laboratory parameters at Day 61 were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"On Day 61","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"classes":[{"title":"ALT, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"50"},{"groupId":"OG002","value":"51"},{"groupId":"OG003","value":"51"},{"groupId":"OG004","value":"65"}]}]},{"title":"ALT, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"4"}]}]},{"title":"ALT, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"AST, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"51"},{"groupId":"OG004","value":"67"}]}]},{"title":"AST, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"}]}]},{"title":"AST, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"54"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Creatinine, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"}]}]},{"title":"Creatinine, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"48"},{"groupId":"OG002","value":"52"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"62"}]}]},{"title":"Creatinine, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"6"}]}]},{"title":"Creatinine, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"55"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"69"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Eosinophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"5"}]}]},{"title":"Eosinophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"60"}]}]},{"title":"Eosinophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"}]}]},{"title":"Eosinophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Hemoglobin, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"67"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"8"}]}]},{"title":"Hemoglobin, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"67"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"46"},{"groupId":"OG002","value":"50"},{"groupId":"OG003","value":"44"},{"groupId":"OG004","value":"58"}]}]},{"title":"Hemoglobin, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"67"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"}]}]},{"title":"Hemoglobin, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"67"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"WBC, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"}]}]},{"title":"WBC, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"61"}]}]},{"title":"WBC, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"3"}]}]},{"title":"WBC, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"66"}]}]},{"title":"Lymphocytes, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"}]}]},{"title":"Neutrophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"61"}]}]},{"title":"Neutrophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"3"}]}]},{"title":"Neutrophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"51"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"65"}]}]},{"title":"Platelets, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"}]}]},{"title":"Platelets, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"53"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"66"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 68","description":"The hematological and biochemical parameters included ALT, AST, creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, WBC. Categories reported when comparing normal range and Day 68 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","populationDescription":"The analysis was performed on the Exposed set. Only the participants with data available for the specified laboratory parameters at Day 68 were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"On Day 68","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"56"}]}],"classes":[{"title":"ALT, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"56"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"47"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"51"},{"groupId":"OG004","value":"51"}]}]},{"title":"ALT, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"56"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"5"}]}]},{"title":"ALT, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"56"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"AST, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"56"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"50"},{"groupId":"OG002","value":"47"},{"groupId":"OG003","value":"51"},{"groupId":"OG004","value":"53"}]}]},{"title":"AST, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"56"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"3"}]}]},{"title":"AST, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"56"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Creatinine, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"56"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"}]}]},{"title":"Creatinine, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"56"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"47"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"51"},{"groupId":"OG004","value":"49"}]}]},{"title":"Creatinine, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"56"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"6"}]}]},{"title":"Creatinine, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"56"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Eosinophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"2"}]}]},{"title":"Eosinophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"50"}]}]},{"title":"Eosinophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"}]}]},{"title":"Eosinophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Hemoglobin, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"12"},{"groupId":"OG004","value":"10"}]}]},{"title":"Hemoglobin, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"43"},{"groupId":"OG003","value":"41"},{"groupId":"OG004","value":"44"}]}]},{"title":"Hemoglobin, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Hemoglobin, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"WBC, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"WBC, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"49"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"53"}]}]},{"title":"WBC, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"}]}]},{"title":"WBC, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]},{"title":"Lymphocytes, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"50"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"53"}]}]},{"title":"Lymphocytes, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]},{"title":"Neutrophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"47"},{"groupId":"OG002","value":"47"},{"groupId":"OG003","value":"52"},{"groupId":"OG004","value":"53"}]}]},{"title":"Neutrophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"49"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"49"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"47"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"51"},{"groupId":"OG004","value":"54"}]}]},{"title":"Platelets, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"49"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"49"},{"groupId":"OG002","value":"49"},{"groupId":"OG003","value":"53"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 181","description":"The hematological and biochemical parameters included ALT, AST, creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, WBC. Categories reported when comparing normal range and Day 181 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","populationDescription":"The analysis was performed on the Exposed Set. Only the participants with data available for the specified laboratory parameters at Day 181 were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"On Day 181","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"classes":[{"title":"ALT, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"46"},{"groupId":"OG004","value":"50"}]}]},{"title":"ALT, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"5"}]}]},{"title":"ALT, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"AST, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"47"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"53"}]}]},{"title":"AST, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"2"}]}]},{"title":"AST, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Creatinine, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"}]}]},{"title":"Creatinine, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"46"},{"groupId":"OG004","value":"46"}]}]},{"title":"Creatinine, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"8"}]}]},{"title":"Creatinine, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"48"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"55"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Eosinophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"1"}]}]},{"title":"Eosinophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"41"},{"groupId":"OG003","value":"44"},{"groupId":"OG004","value":"52"}]}]},{"title":"Eosinophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]},{"title":"Eosinophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Hemoglobin, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"7"}]}]},{"title":"Hemoglobin, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"37"},{"groupId":"OG002","value":"42"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"47"}]}]},{"title":"Hemoglobin, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}]},{"title":"Hemoglobin, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"WBC, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"}]}]},{"title":"WBC, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"42"},{"groupId":"OG002","value":"43"},{"groupId":"OG003","value":"45"},{"groupId":"OG004","value":"53"}]}]},{"title":"WBC, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"}]}]},{"title":"WBC, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"42"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"47"},{"groupId":"OG004","value":"54"}]}]},{"title":"Lymphocytes, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"42"},{"groupId":"OG003","value":"46"},{"groupId":"OG004","value":"54"}]}]},{"title":"Neutrophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"42"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}]},{"title":"Platelets, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"46"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"54"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Hematological and Biochemical Laboratory Abnormalities on Day 188","description":"The hematological and biochemical parameters included ALT, AST, creatinine, eosinophils, hemoglobin, lymphocytes, neutrophils, platelets, WBC. Categories reported when comparing normal range and Day 188 hematological and biochemical laboratory results are defined as follows: \\<parameter\\>, \\<range at timing\\> (e.g. Hemoglobin, Below). Below = value below the laboratory reference range defined for the specified visit and laboratory parameter; Within = value within the laboratory reference range defined for the specified visit and laboratory parameter; Above = value above the laboratory reference range defined for the specified visit and laboratory parameter. Missing = No results are available for the corresponding laboratory parameter at the specific timepoint.","populationDescription":"The analysis was performed on the Exposed Set. Only the participants with data available for the specified laboratory parameters at Day 188 were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"On Day 188","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"classes":[{"title":"ALT, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"41"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"47"}]}]},{"title":"ALT, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"3"}]}]},{"title":"ALT, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"AST, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"42"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"49"}]}]},{"title":"AST, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]},{"title":"AST, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Creatinine, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"0"}]}]},{"title":"Creatinine, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"37"},{"groupId":"OG002","value":"35"},{"groupId":"OG003","value":"45"},{"groupId":"OG004","value":"43"}]}]},{"title":"Creatinine, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"7"}]}]},{"title":"Creatinine, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Eosinophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"}]}]},{"title":"Eosinophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"45"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"40"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"47"}]}]},{"title":"Eosinophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"}]}]},{"title":"Eosinophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Hemoglobin, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"7"}]}]},{"title":"Hemoglobin, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"35"},{"groupId":"OG002","value":"35"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"43"}]}]},{"title":"Hemoglobin, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Hemoglobin, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"WBC, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"WBC, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"42"},{"groupId":"OG003","value":"47"},{"groupId":"OG004","value":"48"}]}]},{"title":"WBC, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"2"}]}]},{"title":"WBC, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"43"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}]},{"title":"Lymphocytes, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Lymphocytes, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"43"},{"groupId":"OG003","value":"47"},{"groupId":"OG004","value":"50"}]}]},{"title":"Neutrophils, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}]},{"title":"Neutrophils, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"40"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"48"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Below","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Within","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"40"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}]},{"title":"Platelets, Above","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]},{"title":"Platelets, Missing","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"49"},{"groupId":"OG004","value":"50"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Unsolicited Events, SAEs, MAEs and Potential Immune Mediated Diseases (pIMDs) From Day 1 to Day 546 (End of Study)","description":"Unsolicited AE=AE that was not included in a list of solicited events using a Participant Diary; the solicited AEs that had an onset after 7 days post each dose administration are considered unsolicited AEs; both serious and non-serious AEs are included. SAE=any untoward medical occurrence that, at any dose, resulted in death, was life-threatening, required hospitalization or prolongation of existing hospitalization, resulted in disability/incapacity, caused a congenital anomaly/birth defect, or was any other situation identified according to medical or scientific judgment. MAE=AE for which the participant received medical attention defined as hospitalization, an emergency room visit or a visit to or from medical personnel (i.e., nurse practitioner or physician assistant or medical doctor) for any reason. pIMDs=a subset of adverse events that include autoimmune diseases and other inflammatory and/or neurological disorders of interest which may or may not have an autoimmune etiology.","populationDescription":"The analysis was performed on the unsolicited Safety Set. Only the participants with any unsolicited adverse events, SAEs, MAEs and pIMDs data available at the specified time period were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Day 1 to Day 546","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"61"},{"groupId":"OG002","value":"60"},{"groupId":"OG003","value":"60"},{"groupId":"OG004","value":"79"}]}],"classes":[{"title":"Unsolicited AEs","categories":[{"measurements":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"27"},{"groupId":"OG002","value":"34"},{"groupId":"OG003","value":"30"},{"groupId":"OG004","value":"31"}]}]},{"title":"SAEs","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"2"}]}]},{"title":"MAEs","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"17"},{"groupId":"OG004","value":"12"}]}]},{"title":"pIMDs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"SECONDARY","title":"Geometric Mean Titers (GMT) of Neutralizing Antibodies (nAbs) Against Epithelial Cell Infection (CMV Status: Sero-positive)","description":"Neutralizing antibodies (nAbs) against epithelial cell infection were measured with neutralizing assay and the results were expressed as GMT.","populationDescription":"The analysis was performed on Per-Protocol Set (PPS),which included participants who received all doses, had immunogenicity results, complied with dosing/blood draw intervals,without intercurrent conditions,without prohibited medication/vaccination. The analysis was done according to the intervention that participants received at Day 1. Only the participants with nAbs against epithelial cell infection (CMV serostatus: sero-positive) data available at the specified time points were reported here.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Titer","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"41"}]}],"classes":[{"title":"Baseline CMV sero-positive, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"41"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2088.2","lowerLimit":"1234.4","upperLimit":"3532.5"},{"groupId":"OG001","value":"1957.2","lowerLimit":"1371.1","upperLimit":"2793.7"},{"groupId":"OG002","value":"2108.2","lowerLimit":"949.1","upperLimit":"4683.1"},{"groupId":"OG003","value":"1683.1","lowerLimit":"1044.9","upperLimit":"2711.2"},{"groupId":"OG004","value":"2594.2","lowerLimit":"2055.2","upperLimit":"3274.6"}]}]},{"title":"Baseline CMV sero-positive, Day 31","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"41"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"18046.5","lowerLimit":"12885.5","upperLimit":"25274.5"},{"groupId":"OG001","value":"15947.5","lowerLimit":"11118.0","upperLimit":"22874.8"},{"groupId":"OG002","value":"19324.1","lowerLimit":"13258.7","upperLimit":"28164.1"},{"groupId":"OG003","value":"21342.4","lowerLimit":"16385.6","upperLimit":"27798.7"},{"groupId":"OG004","value":"2349.7","lowerLimit":"1865.9","upperLimit":"2958.8"}]}]},{"title":"Baseline CMV sero-positive, Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"16783.4","lowerLimit":"10958.5","upperLimit":"25704.7"},{"groupId":"OG001","value":"13982.2","lowerLimit":"9479.4","upperLimit":"20623.9"},{"groupId":"OG002","value":"17609.0","lowerLimit":"9756.5","upperLimit":"31781.5"},{"groupId":"OG003","value":"19393.7","lowerLimit":"14640.9","upperLimit":"25689.4"},{"groupId":"OG004","value":"2437.4","lowerLimit":"1817.7","upperLimit":"3268.4"}]}]},{"title":"Baseline CMV sero-positive, Day 91","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12489.0","lowerLimit":"6822.0","upperLimit":"22863.3"},{"groupId":"OG001","value":"11146.9","lowerLimit":"7187.3","upperLimit":"17288.1"},{"groupId":"OG002","value":"15414.4","lowerLimit":"8835.6","upperLimit":"26891.7"},{"groupId":"OG003","value":"15676.6","lowerLimit":"11712.3","upperLimit":"20982.6"},{"groupId":"OG004","value":"2182.4","lowerLimit":"1648.9","upperLimit":"2888.6"}]}]},{"title":"Baseline CMV sero-positive, Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13925.9","lowerLimit":"8112.5","upperLimit":"23905.4"},{"groupId":"OG001","value":"7431.6","lowerLimit":"4550.5","upperLimit":"12136.7"},{"groupId":"OG002","value":"16663.2","lowerLimit":"9413.9","upperLimit":"29495.1"},{"groupId":"OG003","value":"12040.3","lowerLimit":"7912.7","upperLimit":"18321.0"},{"groupId":"OG004","value":"2236.0","lowerLimit":"1619.0","upperLimit":"3088.1"}]}]},{"title":"Baseline CMV sero-positive, Day 211","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12839.0","lowerLimit":"5484.5","upperLimit":"30055.5"},{"groupId":"OG001","value":"8918.6","lowerLimit":"5285.3","upperLimit":"15049.5"},{"groupId":"OG002","value":"16645.8","lowerLimit":"10020.5","upperLimit":"27651.6"},{"groupId":"OG003","value":"13744.1","lowerLimit":"8248.3","upperLimit":"22901.9"},{"groupId":"OG004","value":"2758.5","lowerLimit":"2003.6","upperLimit":"3797.9"}]}]},{"title":"Baseline CMV sero-positive, Day 361","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"14764.6","lowerLimit":"4612.4","upperLimit":"47262.6"},{"groupId":"OG001","value":"5267.0","lowerLimit":"3313.8","upperLimit":"8371.3"},{"groupId":"OG002","value":"11062.1","lowerLimit":"3954.3","upperLimit":"30946.6"},{"groupId":"OG003","value":"9898.5","lowerLimit":"6425.7","upperLimit":"15248.0"},{"groupId":"OG004","value":"2039.6","lowerLimit":"1489.8","upperLimit":"2792.3"}]}]},{"title":"Baseline CMV sero-positive, Day 546","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"24"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10935.2","lowerLimit":"3900.2","upperLimit":"30659.8"},{"groupId":"OG001","value":"6250.0","lowerLimit":"4063.7","upperLimit":"9612.6"},{"groupId":"OG002","value":"7370.4","lowerLimit":"1470.2","upperLimit":"36950.0"},{"groupId":"OG003","value":"8416.0","lowerLimit":"4937.6","upperLimit":"14345.0"},{"groupId":"OG004","value":"2409.3","lowerLimit":"1844.9","upperLimit":"3146.3"}]}]}]},{"type":"SECONDARY","title":"GMT of nAbs Against Epithelial Cell Infection (CMV Status: Sero-negative)","populationDescription":"The analysis was performed on the PPS. The analysis was done according to the study intervention that participants received at Day 1. Only the participants with nAbs against epithelial cell infection (CMV serostatus: sero-negative) data available at the specified time points were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Titer","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"30"}]}],"classes":[{"title":"Baseline CMV sero-negative, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"42"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"67.6","lowerLimit":"56.4","upperLimit":"81.0"},{"groupId":"OG001","value":"62.7","lowerLimit":"56.4","upperLimit":"69.9"},{"groupId":"OG002","value":"61.4","lowerLimit":"57.6","upperLimit":"65.4"},{"groupId":"OG003","value":"65.5","lowerLimit":"54.0","upperLimit":"79.4"},{"groupId":"OG004","value":"68.5","lowerLimit":"51.4","upperLimit":"91.2"}]}]},{"title":"Baseline CMV sero-negative, Day 31","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"43"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"191.3","lowerLimit":"131.4","upperLimit":"278.5"},{"groupId":"OG001","value":"279.2","lowerLimit":"175.7","upperLimit":"443.7"},{"groupId":"OG002","value":"155.5","lowerLimit":"108.6","upperLimit":"222.6"},{"groupId":"OG003","value":"252.5","lowerLimit":"171.8","upperLimit":"371.1"},{"groupId":"OG004","value":"72.5","lowerLimit":"51.4","upperLimit":"102.5"}]}]},{"title":"Baseline CMV sero-negative, Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"34"},{"groupId":"OG004","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"141.4","lowerLimit":"95.0","upperLimit":"210.6"},{"groupId":"OG001","value":"201.1","lowerLimit":"118.9","upperLimit":"340.3"},{"groupId":"OG002","value":"127.0","lowerLimit":"87.8","upperLimit":"183.6"},{"groupId":"OG003","value":"167.5","lowerLimit":"111.5","upperLimit":"251.6"},{"groupId":"OG004","value":"62.8","lowerLimit":"58.1","upperLimit":"68.0"}]}]},{"title":"Baseline CMV sero-negative, Day 91","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"34"},{"groupId":"OG004","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4743.6","lowerLimit":"3510.8","upperLimit":"6409.4"},{"groupId":"OG001","value":"7831.9","lowerLimit":"5609.7","upperLimit":"10934.3"},{"groupId":"OG002","value":"4485.5","lowerLimit":"3219.3","upperLimit":"6249.7"},{"groupId":"OG003","value":"5150.2","lowerLimit":"4009.3","upperLimit":"6615.8"},{"groupId":"OG004","value":"59.5","lowerLimit":"59.5","upperLimit":"59.5"}]}]},{"title":"Baseline CMV sero-negative, Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"},{"groupId":"OG004","value":"23"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1336.9","lowerLimit":"977.6","upperLimit":"1828.1"},{"groupId":"OG001","value":"2242.6","lowerLimit":"1464.9","upperLimit":"3433.2"},{"groupId":"OG002","value":"1550.1","lowerLimit":"1112.7","upperLimit":"2159.4"},{"groupId":"OG003","value":"1693.8","lowerLimit":"1222.1","upperLimit":"2347.4"},{"groupId":"OG004","value":"81.7","lowerLimit":"51.7","upperLimit":"129.0"}]}]},{"title":"Baseline CMV sero-negative, Day 211","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"},{"groupId":"OG004","value":"22"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8207.8","lowerLimit":"6945.7","upperLimit":"9699.3"},{"groupId":"OG001","value":"9089.4","lowerLimit":"6883.7","upperLimit":"12001.9"},{"groupId":"OG002","value":"5848.5","lowerLimit":"4690.5","upperLimit":"7292.2"},{"groupId":"OG003","value":"7285.0","lowerLimit":"5930.8","upperLimit":"8948.3"},{"groupId":"OG004","value":"78.2","lowerLimit":"48.7","upperLimit":"125.4"}]}]},{"title":"Baseline CMV sero-negative, Day 361","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"},{"groupId":"OG004","value":"20"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2398.1","lowerLimit":"1832.3","upperLimit":"3138.5"},{"groupId":"OG001","value":"3017.0","lowerLimit":"2201.7","upperLimit":"4134.2"},{"groupId":"OG002","value":"1649.4","lowerLimit":"1110.5","upperLimit":"2449.9"},{"groupId":"OG003","value":"1696.6","lowerLimit":"1146.1","upperLimit":"2511.5"},{"groupId":"OG004","value":"114.4","lowerLimit":"60.0","upperLimit":"218.1"}]}]},{"title":"Baseline CMV sero-negative, Day 546","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"29"},{"groupId":"OG004","value":"19"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1550.6","lowerLimit":"1193.7","upperLimit":"2014.3"},{"groupId":"OG001","value":"1896.8","lowerLimit":"1360.7","upperLimit":"2644.1"},{"groupId":"OG002","value":"1326.3","lowerLimit":"960.7","upperLimit":"1831.0"},{"groupId":"OG003","value":"1308.5","lowerLimit":"967.3","upperLimit":"1770.1"},{"groupId":"OG004","value":"88.9","lowerLimit":"49.6","upperLimit":"159.3"}]}]}]},{"type":"SECONDARY","title":"Geometric Mean Concentration (GMC) of Anti-pentamer Immunoglobulin G (IgG) (CMV Serostaus: Sero-positive)","description":"The vaccine-induced humoral immunity was quantified by measuring the concentration of the anti-pentamer by enzyme-linked immunosorbent assay (ELISA).","populationDescription":"The analysis was performed on the PPS. Only the participants with anti-pentamer IgG (CMV serostatus: seropositive) data available at the specified time points were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"ELISA units per milliliter (EU/mL)","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"41"}]}],"classes":[{"title":"Baseline CMV sero-positive, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"41"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4162.4","lowerLimit":"2514.0","upperLimit":"6891.5"},{"groupId":"OG001","value":"4646.4","lowerLimit":"2682.4","upperLimit":"8048.4"},{"groupId":"OG002","value":"4415.3","lowerLimit":"1693.8","upperLimit":"11509.7"},{"groupId":"OG003","value":"3356.3","lowerLimit":"2085.6","upperLimit":"5401.4"},{"groupId":"OG004","value":"5955.3","lowerLimit":"4680.0","upperLimit":"7578.1"}]}]},{"title":"Baseline CMV sero-positive, Day 31","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"41"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"63206.8","lowerLimit":"48896.4","upperLimit":"81705.6"},{"groupId":"OG001","value":"76136.0","lowerLimit":"69483.5","upperLimit":"83425.5"},{"groupId":"OG002","value":"70053.1","lowerLimit":"52026.6","upperLimit":"94325.4"},{"groupId":"OG003","value":"75963.4","lowerLimit":"70516.7","upperLimit":"81830.8"},{"groupId":"OG004","value":"6405.5","lowerLimit":"4987.0","upperLimit":"8227.6"}]}]},{"title":"Baseline CMV sero-positive, Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"56100.2","lowerLimit":"32989.4","upperLimit":"95401.2"},{"groupId":"OG001","value":"61055.1","lowerLimit":"47694.3","upperLimit":"78158.8"},{"groupId":"OG002","value":"60309.2","lowerLimit":"32055.0","upperLimit":"113467.5"},{"groupId":"OG003","value":"69559.3","lowerLimit":"62320.3","upperLimit":"77639.2"},{"groupId":"OG004","value":"5122.9","lowerLimit":"3866.5","upperLimit":"6787.5"}]}]},{"title":"Baseline CMV sero-positive, Day 91","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"52956.8","lowerLimit":"26623.7","upperLimit":"105335.8"},{"groupId":"OG001","value":"56759.7","lowerLimit":"44693.2","upperLimit":"72083.9"},{"groupId":"OG002","value":"69114.3","lowerLimit":"54301.6","upperLimit":"87967.8"},{"groupId":"OG003","value":"65006.2","lowerLimit":"55733.8","upperLimit":"75821.3"},{"groupId":"OG004","value":"5378.7","lowerLimit":"4034.5","upperLimit":"7170.8"}]}]},{"title":"Baseline CMV sero-positive, Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"60978.8","lowerLimit":"26275.7","upperLimit":"141515.2"},{"groupId":"OG001","value":"40817.7","lowerLimit":"23675.7","upperLimit":"70370.8"},{"groupId":"OG002","value":"60500.5","lowerLimit":"40484.4","upperLimit":"90412.8"},{"groupId":"OG003","value":"13228.6","lowerLimit":"1561.4","upperLimit":"112075.8"},{"groupId":"OG004","value":"2800.3","lowerLimit":"1408.0","upperLimit":"5569.2"}]}]},{"title":"Baseline CMV sero-positive, Day 211","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"61922.5","lowerLimit":"28018.8","upperLimit":"136850.7"},{"groupId":"OG001","value":"45090.5","lowerLimit":"27322.5","upperLimit":"74413.0"},{"groupId":"OG002","value":"64013.9","lowerLimit":"44918.5","upperLimit":"91227.1"},{"groupId":"OG003","value":"65791.3","lowerLimit":"56786.7","upperLimit":"76223.8"},{"groupId":"OG004","value":"5707.8","lowerLimit":"3973.2","upperLimit":"8199.7"}]}]},{"title":"Baseline CMV sero-positive, Day 361","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"70275.0","lowerLimit":"41466.6","upperLimit":"119097.5"},{"groupId":"OG001","value":"25395.5","lowerLimit":"15173.0","upperLimit":"42505.2"},{"groupId":"OG002","value":"3675.9","lowerLimit":"26.5","upperLimit":"510252.9"},{"groupId":"OG003","value":"21439.5","lowerLimit":"4528.7","upperLimit":"101498.0"},{"groupId":"OG004","value":"4256.4","lowerLimit":"2607.6","upperLimit":"6947.5"}]}]},{"title":"Baseline CMV sero-positive, Day 546","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"24"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"73801.2","lowerLimit":"60655.6","upperLimit":"89795.9"},{"groupId":"OG001","value":"22318.0","lowerLimit":"13478.9","upperLimit":"36953.6"},{"groupId":"OG002","value":"27775.9","lowerLimit":"6435.5","upperLimit":"119881.1"},{"groupId":"OG003","value":"30501.0","lowerLimit":"20218.3","upperLimit":"46013.4"},{"groupId":"OG004","value":"5507.3","lowerLimit":"4226.8","upperLimit":"7175.9"}]}]}]},{"type":"SECONDARY","title":"GMC of Anti-pentamer IgG (CMV Serostatus: Sero-negative)","populationDescription":"The analysis was performed on the PPS. Only the participants with anti-pentamer IgG (CMV serostatus: sero-negative) data available at the specified time points were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"ELISA units per milliliter (EU/mL)","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"30"}]}],"classes":[{"title":"Baseline CMV sero-negative, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"42"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"55.8","lowerLimit":"44.4","upperLimit":"70.3"},{"groupId":"OG001","value":"52.8","lowerLimit":"45.1","upperLimit":"61.7"},{"groupId":"OG002","value":"53.3","lowerLimit":"45.8","upperLimit":"62.1"},{"groupId":"OG003","value":"52.9","lowerLimit":"42.6","upperLimit":"65.7"},{"groupId":"OG004","value":"54.4","lowerLimit":"41.2","upperLimit":"71.7"}]}]},{"title":"Baseline CMV sero-negative, Day 31","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3801.8","lowerLimit":"2577.6","upperLimit":"5607.3"},{"groupId":"OG001","value":"4912.6","lowerLimit":"3022.0","upperLimit":"7986.0"},{"groupId":"OG002","value":"3552.8","lowerLimit":"2631.7","upperLimit":"4796.4"},{"groupId":"OG003","value":"4184.6","lowerLimit":"2875.4","upperLimit":"6090.0"},{"groupId":"OG004","value":"55.4","lowerLimit":"42.5","upperLimit":"72.2"}]}]},{"title":"Baseline CMV sero-negative, Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"34"},{"groupId":"OG004","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2312.8","lowerLimit":"1527.2","upperLimit":"3502.4"},{"groupId":"OG001","value":"2825.6","lowerLimit":"1666.2","upperLimit":"4791.9"},{"groupId":"OG002","value":"1957.5","lowerLimit":"1413.9","upperLimit":"2710.1"},{"groupId":"OG003","value":"2430.0","lowerLimit":"1531.3","upperLimit":"3856.2"},{"groupId":"OG004","value":"47.5","lowerLimit":"47.5","upperLimit":"47.5"}]}]},{"title":"Baseline CMV sero-negative, Day 91","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"34"},{"groupId":"OG004","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"66744.1","lowerLimit":"58610.1","upperLimit":"76007.0"},{"groupId":"OG001","value":"70244.9","lowerLimit":"58431.0","upperLimit":"84447.3"},{"groupId":"OG002","value":"51455.6","lowerLimit":"32470.0","upperLimit":"81542.2"},{"groupId":"OG003","value":"69461.5","lowerLimit":"63415.7","upperLimit":"76083.6"},{"groupId":"OG004","value":"47.5","lowerLimit":"47.5","upperLimit":"47.5"}]}]},{"title":"Baseline CMV sero-negative, Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"},{"groupId":"OG004","value":"23"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19362.4","lowerLimit":"15121.9","upperLimit":"24792.1"},{"groupId":"OG001","value":"19634.4","lowerLimit":"11567.7","upperLimit":"33326.6"},{"groupId":"OG002","value":"10273.3","lowerLimit":"5119.0","upperLimit":"20617.8"},{"groupId":"OG003","value":"14505.2","lowerLimit":"9273.2","upperLimit":"22689.2"},{"groupId":"OG004","value":"55.7","lowerLimit":"40.1","upperLimit":"77.4"}]}]},{"title":"Baseline CMV sero-negative, Day 211","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"},{"groupId":"OG004","value":"22"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"55233.1","lowerLimit":"48376.1","upperLimit":"63062.0"},{"groupId":"OG001","value":"60289.8","lowerLimit":"50895.1","upperLimit":"71418.7"},{"groupId":"OG002","value":"17170.6","lowerLimit":"6741.2","upperLimit":"43735.5"},{"groupId":"OG003","value":"24218.4","lowerLimit":"10137.9","upperLimit":"57855.3"},{"groupId":"OG004","value":"57.3","lowerLimit":"38.8","upperLimit":"84.5"}]}]},{"title":"Baseline CMV sero-negative, Day 361","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"},{"groupId":"OG004","value":"20"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19123.4","lowerLimit":"15704.0","upperLimit":"23287.5"},{"groupId":"OG001","value":"13379.6","lowerLimit":"6989.0","upperLimit":"25613.7"},{"groupId":"OG002","value":"17229.0","lowerLimit":"13799.9","upperLimit":"21510.3"},{"groupId":"OG003","value":"17149.4","lowerLimit":"13631.3","upperLimit":"21575.4"},{"groupId":"OG004","value":"47.5","lowerLimit":"47.5","upperLimit":"47.5"}]}]},{"title":"Baseline CMV sero-negative, Day 546","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"29"},{"groupId":"OG004","value":"19"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10525.2","lowerLimit":"8332.4","upperLimit":"13295.2"},{"groupId":"OG001","value":"12054.1","lowerLimit":"9028.6","upperLimit":"16093.4"},{"groupId":"OG002","value":"8678.1","lowerLimit":"6671.2","upperLimit":"11288.7"},{"groupId":"OG003","value":"9490.6","lowerLimit":"7421.7","upperLimit":"12136.4"},{"groupId":"OG004","value":"75.2","lowerLimit":"38.7","upperLimit":"146.1"}]}]}]},{"type":"SECONDARY","title":"GMC of Anti-glycoprotein B (gB) IgG (CMV Serostaus: Sero-positive)","description":"The vaccine-induced humoral immunity was quantified by measuring the concentration of the anti-gB IgG binding antibodies by ELISA.","populationDescription":"The analysis was performed on the PPS. Only the participants with anti-gB IgG (CMV serostatus: sero-positive) data available at the specified time points were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"EU/mL","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"41"}]}],"classes":[{"title":"Baseline CMV sero-positive, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"41"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"16807.2","lowerLimit":"9740.9","upperLimit":"28999.8"},{"groupId":"OG001","value":"14677.4","lowerLimit":"8313.5","upperLimit":"25913.1"},{"groupId":"OG002","value":"20120.7","lowerLimit":"9509.5","upperLimit":"42572.1"},{"groupId":"OG003","value":"16221.5","lowerLimit":"10271.5","upperLimit":"25618.0"},{"groupId":"OG004","value":"21199.1","lowerLimit":"17495.5","upperLimit":"25686.7"}]}]},{"title":"Baseline CMV sero-positive, Day 31","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"41"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"66740.2","lowerLimit":"46249.9","upperLimit":"96308.3"},{"groupId":"OG001","value":"69713.1","lowerLimit":"52294.9","upperLimit":"92932.8"},{"groupId":"OG002","value":"109132.0","lowerLimit":"53451.6","upperLimit":"222814.6"},{"groupId":"OG003","value":"75579.9","lowerLimit":"51122.6","upperLimit":"111737.6"},{"groupId":"OG004","value":"18257.1","lowerLimit":"15052.4","upperLimit":"22144.1"}]}]},{"title":"Baseline CMV sero-positive, Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"58273.9","lowerLimit":"34831.0","upperLimit":"97495.0"},{"groupId":"OG001","value":"48404.7","lowerLimit":"35588.2","upperLimit":"65836.8"},{"groupId":"OG002","value":"91039.0","lowerLimit":"32744.9","upperLimit":"253111.6"},{"groupId":"OG003","value":"53782.6","lowerLimit":"38766.2","upperLimit":"74615.6"},{"groupId":"OG004","value":"16443.7","lowerLimit":"12861.7","upperLimit":"21023.3"}]}]},{"title":"Baseline CMV sero-positive, Day 91","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"32"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"53127.7","lowerLimit":"26680.1","upperLimit":"105792.5"},{"groupId":"OG001","value":"62024.7","lowerLimit":"37691.3","upperLimit":"102067.7"},{"groupId":"OG002","value":"88624.7","lowerLimit":"42041.2","upperLimit":"186824.8"},{"groupId":"OG003","value":"62028.8","lowerLimit":"43352.1","upperLimit":"88751.7"},{"groupId":"OG004","value":"15985.6","lowerLimit":"12566.4","upperLimit":"20335.1"}]}]},{"title":"Baseline CMV sero-positive, Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"44748.5","lowerLimit":"17636.2","upperLimit":"113541.0"},{"groupId":"OG001","value":"37511.5","lowerLimit":"23630.5","upperLimit":"59546.2"},{"groupId":"OG002","value":"67095.8","lowerLimit":"30105.2","upperLimit":"149537.2"},{"groupId":"OG003","value":"49659.4","lowerLimit":"32576.5","upperLimit":"75700.7"},{"groupId":"OG004","value":"15348.4","lowerLimit":"11822.3","upperLimit":"19926.2"}]}]},{"title":"Baseline CMV sero-positive, Day 211","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"75673.6","lowerLimit":"33600.3","upperLimit":"170429.8"},{"groupId":"OG001","value":"50995.3","lowerLimit":"36520.7","upperLimit":"71206.7"},{"groupId":"OG002","value":"87492.4","lowerLimit":"41876.8","upperLimit":"182796.1"},{"groupId":"OG003","value":"66691.8","lowerLimit":"46959.4","upperLimit":"94715.8"},{"groupId":"OG004","value":"18067.2","lowerLimit":"13697.6","upperLimit":"23830.7"}]}]},{"title":"Baseline CMV sero-positive, Day 361","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"41336.4","lowerLimit":"11371.3","upperLimit":"150263.9"},{"groupId":"OG001","value":"25672.0","lowerLimit":"16619.1","upperLimit":"39656.3"},{"groupId":"OG002","value":"46282.5","lowerLimit":"17872.4","upperLimit":"119853.8"},{"groupId":"OG003","value":"42016.5","lowerLimit":"27743.1","upperLimit":"63633.2"},{"groupId":"OG004","value":"16143.7","lowerLimit":"12395.5","upperLimit":"21025.3"}]}]},{"title":"Baseline CMV sero-positive, Day 546","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"24"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"39486.4","lowerLimit":"8878.6","upperLimit":"175610.6"},{"groupId":"OG001","value":"29253.1","lowerLimit":"17866.2","upperLimit":"47897.4"},{"groupId":"OG002","value":"28078.7","lowerLimit":"4686.8","upperLimit":"168221.4"},{"groupId":"OG003","value":"25090.5","lowerLimit":"15797.9","upperLimit":"39848.9"},{"groupId":"OG004","value":"18446.5","lowerLimit":"14655.6","upperLimit":"23218.0"}]}]}]},{"type":"SECONDARY","title":"GMC of Anti-gB IgG (CMV Serostatus: Sero-negative)","populationDescription":"The analysis was performed on the PPS. Only the participants with anti-gB IgG (CMV serostatus: sero-negative) data available at the specified time points were reported in this outcome measure.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"EU/mL","timeFrame":"On Day 1, Day 31, Day 61, Day 91, Day 181, Day 211, Day 361 and Day 546","groups":[{"id":"OG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly."},{"id":"OG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"30"}]}],"classes":[{"title":"Baseline CMV sero-negative, Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"42"},{"groupId":"OG002","value":"45"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"102.5","lowerLimit":"81.0","upperLimit":"129.8"},{"groupId":"OG001","value":"114.4","lowerLimit":"88.7","upperLimit":"147.7"},{"groupId":"OG002","value":"93.1","lowerLimit":"80.3","upperLimit":"107.9"},{"groupId":"OG003","value":"101.7","lowerLimit":"78.3","upperLimit":"132.1"},{"groupId":"OG004","value":"113.8","lowerLimit":"75.7","upperLimit":"171.3"}]}]},{"title":"Baseline CMV sero-negative, Day 31","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"44"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6043.1","lowerLimit":"4257.1","upperLimit":"8578.3"},{"groupId":"OG001","value":"7071.6","lowerLimit":"4512.9","upperLimit":"11080.9"},{"groupId":"OG002","value":"10176.1","lowerLimit":"7768.5","upperLimit":"13329.8"},{"groupId":"OG003","value":"6067.3","lowerLimit":"4321.0","upperLimit":"8519.2"},{"groupId":"OG004","value":"114.0","lowerLimit":"76.0","upperLimit":"170.9"}]}]},{"title":"Baseline CMV sero-negative, Day 61","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"34"},{"groupId":"OG004","value":"29"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4208.8","lowerLimit":"2785.6","upperLimit":"6359.1"},{"groupId":"OG001","value":"5081.6","lowerLimit":"2805.1","upperLimit":"9205.9"},{"groupId":"OG002","value":"7192.3","lowerLimit":"4952.9","upperLimit":"10444.0"},{"groupId":"OG003","value":"3864.8","lowerLimit":"2484.8","upperLimit":"6011.2"},{"groupId":"OG004","value":"97.0","lowerLimit":"74.7","upperLimit":"126.1"}]}]},{"title":"Baseline CMV sero-negative, Day 91","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"34"},{"groupId":"OG004","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"29126.7","lowerLimit":"21569.8","upperLimit":"39331.0"},{"groupId":"OG001","value":"26239.9","lowerLimit":"18732.0","upperLimit":"36756.9"},{"groupId":"OG002","value":"38193.4","lowerLimit":"28885.8","upperLimit":"50500.1"},{"groupId":"OG003","value":"22817.2","lowerLimit":"17650.9","upperLimit":"29495.7"},{"groupId":"OG004","value":"97.0","lowerLimit":"74.6","upperLimit":"126.0"}]}]},{"title":"Baseline CMV sero-negative, Day 181","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"},{"groupId":"OG004","value":"23"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10447.1","lowerLimit":"7843.8","upperLimit":"13914.6"},{"groupId":"OG001","value":"10571.4","lowerLimit":"7042.6","upperLimit":"15868.4"},{"groupId":"OG002","value":"15910.9","lowerLimit":"12022.6","upperLimit":"21056.5"},{"groupId":"OG003","value":"7623.1","lowerLimit":"5559.4","upperLimit":"10452.7"},{"groupId":"OG004","value":"132.9","lowerLimit":"79.1","upperLimit":"223.2"}]}]},{"title":"Baseline CMV sero-negative, Day 211","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"},{"groupId":"OG004","value":"22"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"41716.8","lowerLimit":"33282.1","upperLimit":"52289.2"},{"groupId":"OG001","value":"38078.9","lowerLimit":"28547.2","upperLimit":"50793.2"},{"groupId":"OG002","value":"41517.5","lowerLimit":"33542.7","upperLimit":"51388.5"},{"groupId":"OG003","value":"33650.3","lowerLimit":"26408.3","upperLimit":"42878.1"},{"groupId":"OG004","value":"138.2","lowerLimit":"78.0","upperLimit":"244.6"}]}]},{"title":"Baseline CMV sero-negative, Day 361","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"},{"groupId":"OG004","value":"20"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"14449.2","lowerLimit":"11224.6","upperLimit":"18600.1"},{"groupId":"OG001","value":"12622.8","lowerLimit":"9090.0","upperLimit":"17528.6"},{"groupId":"OG002","value":"15316.6","lowerLimit":"12029.6","upperLimit":"19501.8"},{"groupId":"OG003","value":"8469.1","lowerLimit":"6491.5","upperLimit":"11049.1"},{"groupId":"OG004","value":"113.7","lowerLimit":"75.2","upperLimit":"171.9"}]}]},{"title":"Baseline CMV sero-negative, Day 546","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"29"},{"groupId":"OG004","value":"19"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8577.8","lowerLimit":"6400.7","upperLimit":"11495.5"},{"groupId":"OG001","value":"7258.8","lowerLimit":"5030.1","upperLimit":"10475.0"},{"groupId":"OG002","value":"8975.2","lowerLimit":"6742.6","upperLimit":"11947.2"},{"groupId":"OG003","value":"5066.8","lowerLimit":"3908.4","upperLimit":"6568.5"},{"groupId":"OG004","value":"190.3","lowerLimit":"76.6","upperLimit":"472.5"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"Solicited events: within 7 days post-dose (doses administered on Day 1, Day 61 and Day 181); All-cause mortality, unsolicited AEs, SAEs, MAEs and pIMDs: from Day 1 to Day 546","description":"Solicited and unsolicited adverse events were reported per participant, after any vaccination, for the assessed timeframe according to occurrence of each event. All events presented in the All-cause mortality, SAE and Other (not including Serious) AEs are reported for the Exposed set.","eventGroups":[{"id":"EG000","title":"Pentamer (Low Dose)/Glycoprotein B (gB) (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate cytomegalovirus (CMV) vaccine consisting of a combination of low dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly.","deathsNumAffected":0,"deathsNumAtRisk":69,"seriousNumAffected":3,"seriousNumAtRisk":69,"otherNumAffected":62,"otherNumAtRisk":69},{"id":"EG001","title":"Pentamer (Medium Dose)/gB (Low Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and low dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly.","deathsNumAffected":0,"deathsNumAtRisk":61,"seriousNumAffected":1,"seriousNumAtRisk":61,"otherNumAffected":58,"otherNumAtRisk":61},{"id":"EG002","title":"Pentamer (Medium Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of medium dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly.","deathsNumAffected":0,"deathsNumAtRisk":60,"seriousNumAffected":0,"seriousNumAtRisk":60,"otherNumAffected":56,"otherNumAtRisk":60},{"id":"EG003","title":"Pentamer (High Dose)/gB (Medium Dose)/Adjuvant Group","description":"Participants received a dose of the candidate CMV vaccine consisting of a combination of high dose of pentamer and medium dose of gB antigens, adjuvanted, at Day 1, Day 61 and Day 181 intramuscularly.","deathsNumAffected":1,"deathsNumAtRisk":60,"seriousNumAffected":3,"seriousNumAtRisk":60,"otherNumAffected":56,"otherNumAtRisk":60},{"id":"EG004","title":"Placebo Group","description":"Participants received a dose of placebo at Day 1, Day 61 and Day 181 intramuscularly.","deathsNumAffected":0,"deathsNumAtRisk":79,"seriousNumAffected":2,"seriousNumAtRisk":79,"otherNumAffected":46,"otherNumAtRisk":79}],"seriousEvents":[{"term":"Abortion spontaneous","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 28.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":69},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":61},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":79}]},{"term":"Bipolar disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 28.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":69},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":61},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":60},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":79}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 28.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":69},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":61},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":79}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 28.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":69},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":61},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":79}]},{"term":"Road traffic accident","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 28.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":69},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":61},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":60},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":79}]},{"term":"Intervertebral disc protrusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 28.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":69},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":61},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":79}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 28.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":69},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":61},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":60},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":79}]}],"otherEvents":[{"term":"Administration site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":52,"numAffected":52,"numAtRisk":69},{"groupId":"EG001","numEvents":47,"numAffected":47,"numAtRisk":61},{"groupId":"EG002","numEvents":45,"numAffected":45,"numAtRisk":60},{"groupId":"EG003","numEvents":47,"numAffected":47,"numAtRisk":60},{"groupId":"EG004","numEvents":5,"numAffected":5,"numAtRisk":79}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":44,"numAffected":44,"numAtRisk":69},{"groupId":"EG001","numEvents":47,"numAffected":47,"numAtRisk":61},{"groupId":"EG002","numEvents":43,"numAffected":43,"numAtRisk":60},{"groupId":"EG003","numEvents":39,"numAffected":39,"numAtRisk":60},{"groupId":"EG004","numEvents":21,"numAffected":21,"numAtRisk":79}]},{"term":"Administration site erythema","organSystem":"General disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":69},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":61},{"groupId":"EG002","numEvents":6,"numAffected":6,"numAtRisk":60},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":60},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":79}]},{"term":"Administration site swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":69},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":61},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":60},{"groupId":"EG003","numEvents":6,"numAffected":6,"numAtRisk":60},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":79}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":69},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":61},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":60},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":60},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":79}]},{"term":"Injection site pruritus","organSystem":"General disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":69},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":61},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":60},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":79}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":40,"numAffected":40,"numAtRisk":69},{"groupId":"EG001","numEvents":36,"numAffected":36,"numAtRisk":61},{"groupId":"EG002","numEvents":33,"numAffected":33,"numAtRisk":60},{"groupId":"EG003","numEvents":44,"numAffected":44,"numAtRisk":60},{"groupId":"EG004","numEvents":6,"numAffected":6,"numAtRisk":79}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":17,"numAffected":17,"numAtRisk":69},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":61},{"groupId":"EG002","numEvents":18,"numAffected":18,"numAtRisk":60},{"groupId":"EG003","numEvents":18,"numAffected":18,"numAtRisk":60},{"groupId":"EG004","numEvents":4,"numAffected":4,"numAtRisk":79}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":37,"numAffected":37,"numAtRisk":69},{"groupId":"EG001","numEvents":38,"numAffected":38,"numAtRisk":61},{"groupId":"EG002","numEvents":32,"numAffected":32,"numAtRisk":60},{"groupId":"EG003","numEvents":32,"numAffected":32,"numAtRisk":60},{"groupId":"EG004","numEvents":16,"numAffected":16,"numAtRisk":79}]},{"term":"COVID-19","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":69},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":61},{"groupId":"EG002","numEvents":6,"numAffected":6,"numAtRisk":60},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":60},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":79}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":69},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":61},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":60},{"groupId":"EG003","numEvents":5,"numAffected":5,"numAtRisk":60},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":79}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":69},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":61},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":60},{"groupId":"EG003","numEvents":5,"numAffected":5,"numAtRisk":60},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":79}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":69},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":61},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":60},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":60},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":79}]},{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":69},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":61},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":60},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":60},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":79}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"GSK Response Center","organization":"GlaxoSmithKline","email":"GSKClinicalSupportHD@gsk.com","phone":"866-435-7343"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2024-05-02","uploadDate":"2026-03-31T07:50","filename":"Prot_000.pdf","size":1859167},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2025-03-18","uploadDate":"2026-03-31T07:50","filename":"SAP_001.pdf","size":749715}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09","submissionTracking":{"firstMcpInfo":{"postDateStruct":{"date":"2026-04-21","type":"ACTUAL"}}}},"conditionBrowseModule":{"meshes":[{"id":"D003586","term":"Cytomegalovirus Infections"}],"ancestors":[{"id":"D006566","term":"Herpesviridae Infections"},{"id":"D004266","term":"DNA Virus Infections"},{"id":"D014777","term":"Virus Diseases"},{"id":"D007239","term":"Infections"}]},"interventionBrowseModule":{"meshes":[{"id":"D000077330","term":"Saline Solution"}],"ancestors":[{"id":"D000077324","term":"Crystalloid Solutions"},{"id":"D007552","term":"Isotonic Solutions"},{"id":"D012996","term":"Solutions"},{"id":"D004364","term":"Pharmaceutical Preparations"}]}},"hasResults":true}